Makers Laboratories

₹223.62As of Sun 8 Nov 2026, 12:00 UTC
NSE:MAKERSL—
Country India
PE (Fwd) 69.87
TSR 10Y CAGR —
Div yield —
ROE —
Pharmaceutical Preparations
Beta (5Y) 0.17
PE TTM 56.12
TSR TTM —
Mkt cap ₹1.576B
ROIC —
SE Grade™
Value
Quality
Moat
1Y Price
Reference
₹244
—
9.23%
—
—
FY23
FY24
FY25
FY26
Earnings per share₹
(7.90)
(10.62)
12.70
3.98
(178.03%)
(34.43%)
219.54%
(68.61%)
Revenue₹B
1.013
1.044
1.211
1.409
(20.98%)
3.07%
16.03%
16.30%
TTM
FYE 31 Mar INR
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
FY2027E
Trend
5Y
10Y
Peers
1.409
Revenue₹B
—
—
—
—
—
1.282
1.013
1.044
1.211
1.409
1.445
2.39%
2.39%
59
16.30
Revenue growth%
—
—
—
—
—
—
(20.98)
3.07
16.03
16.30
2.59
9.55
—
78
51.45
Gross margin%
—
—
—
—
—
58.08
58.25
46.17
53.30
51.45
51.45
53.30
53.30
74
7.41
Operating margin%
—
—
—
—
—
12.55
(0.53)
(2.90)
3.28
7.41
7.00
3.28
3.28
85
1.67
Net margin%
—
—
—
—
—
3.88
(4.69)
(6.00)
6.18
1.67
1.40
1.67
1.67
74
56.12
P/E ratio (avg)x
—
—
—
—
—
—
—
—
—
—
65.16
—
—
41
12.64
EV/EBITx
—
—
—
—
—
—
—
—
—
—
13.04
—
—
77
—
FCF yield (avg)%
—
—
—
—
—
—
—
—
—
—
—
—
—
81
—
FCF margin%
—
—
—
—
—
—
—
—
—
—
—
—
—
81
—
FCF / Net incomex
—
—
—
—
—
—
—
—
—
—
—
—
—
88
—
ROIC%
—
—
—
—
—
—
—
—
—
—
—
—
—
96
—
Return on equity%
—
—
—
—
—
—
—
—
—
—
—
—
—
88
—
Return on assets%
—
—
—
—
—
—
—
—
—
—
—
—
—
93
3.99
EPS₹
—
—
—
—
—
10.12
(7.90)
(10.62)
12.70
3.99
3.43
(20.79%)
(20.79%)
—
(68.61)
EPS growth%
—
—
—
—
—
—
(178.02)
(34.39)
219.58
(68.61)
(13.87)
(51.50)
—
—
—
Bookvalue per sh₹
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
FCF per share₹
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
Dividend per sh₹
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
Div yield (avg)%
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
Payout ratio%
—
—
—
—
—
—
—
—
—
—
—
—
—
—
5.900
Shares (diluted)M
—
—
—
—
—
4.917
6.014
5.900
5.900
5.900
◌5.900
4.66%
4.66%
87
—
Buyback yield%
—
—
—
—
—
—
(22.31)
1.89
—
—
◌—
—
—
87
—
D/E ratiox
—
—
—
—
—
—
—
—
—
—
—
—
—
77
1.319
Enterprise value₹B
—
—
—
—
—
—
—
—
—
—
1.319
—
—
50
—
LT debt₹M
—
—
—
—
—
—
—
—
—
—
—
—
—
19
Peers (US$13.46M)
Cap (US$)
PE
12.91M
23.79x
12.48M
13.25x
Capital
TTM
5Y
10Y
Leveragex
—
—
—
EBIT/Intx
16.12
3.674
3.674
Own earn%
—
—
—
Sh yield%
—
—
—
Owners
Insiders/Inst%
12.34
—
Short interest%
—
SBC / revenue%
—
Record
10Y
Profitable years
3/5
Revenue growth years
3/4
EPS growth years
1/4
Dividend streakyrs
0
Op margin range%
−3–13
$1 testx
—
Incr. ROIC%
—

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing.

Growth vs revenue
Latest
Trend
4Y CAGR
Rel growth
Revenue
₹1.409B
2.39%
1.00×
Cost of revenue
₹683.9M
6.22%
1.16×
Operating expenses
₹620.4M
1.54%
0.97×
Revenue by region
No breakdown available
Reinvestment returns
n/m
Trend
Reinvestment rate
n/m
-
Return on capital
n/m
-
Spread over hurdle
n/m
-